EUBIOLOGICS CO., LTD.

Press Releases EuBiologics Co., Ltd.

Equities

A206650

KR7206650004

End-of-day quote Korea S.E. Other stock markets 23:00:00 20/05/2024 BST			5-day change	1st Jan Change
12,340 ^KRW	-2.14%		-3.89%	+7.59%

01-29	Zimbabwe launches door-to-door cholera vaccination campaign	RE
2023	Pop Biotechnologies and Eubiologics' Eucorvac-19 Vaccine Hits Target in Phase 3 Trial	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

EuBiologics co.,Ltd - SNAP Platform enters Phase I clinical studies for RSV	05-13	AQ
Gavi and UNICEF welcome approval of new oral cholera vaccine	04-19	AQ
Gavi and Unicef Welcome Approval of New Oral Cholera Vaccine [press release]	04-19	AQ
What's Behind the Worldwide Shortage of Cholera Vaccines? for Starters, They're Only Made By One Company [analysis]	03-13	AQ
Gavi - Global vaccine alliance outlines path to sustainable cholera vaccine supply	23/05/23	AQ
POP Biotechnologies' SNAP Vaccine System Safe and Effective in a Phase II Clinical Trial for COVID-19	01/12/22	AQ
POP Biotechnologies' next-gen vaccine technology to enter COVID-19 phase III clinical trials	07/02/22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer